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Abstract 
 
S,S,S-Tris(2-ethylhexyl) phosphorotrithioate proved an effective solvent 
mediator for constructing a mexiletine-sensitive membrane electrode in 
combination with an ion-exchanger, sodium 
tetrakis[3,5-bis(2-methoxyhexafluoro-2-propyl)phenyl]borate. Among a series of 
phosphorus compounds containing phosphoryl (P=O) groups, this solvent 
mediator showed the highest sensitivity to mexiletine in phosphate-buffered 
physiological saline containing 0.15 mol L–1 NaCl and 0.01 mol L–1 
NaH2PO4/Na2HPO4 (pH 7.4), giving a detection limit of 2×10–6 mol L–1 with a 
slope of 58.8 mV decade–1. This is the best detection limit of any mexiletine 
electrode developed to date. Having high selectivity toward inorganic cations, the 
electrode was used to determine the level of mexiletine in saliva, the monitoring 
of which is quite effective for controlling the dose of this drug noninvasively. The 
mexiletine concentrations determined with the mexiletine electrode compared 
favorably with those determined by high-performance liquid chromatography. 
 
Keywords Ion-selective electrode • Mexiletine determination • 
S,S,S-Tris(2-ethylhexyl) phosphorotrithioate • Solvent mediator • Drug 
monitoring
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Introduction 
 
     There have been few studies devoted to the development of ion-selective 
electrodes based on the hydrogen-bonding interaction between host and guest 
molecules [1–8]. Typical examples are the use of hydrogen-bonding ionophores 
with urea or thiourea units, which were successfully employed to produce 
anion-selective electrodes, including those specific to nucleotides, Cl–, SO42–, and 
acetate [2–5]. Hydrogen-bonding solvent mediators have also been used to 
construct certain specific organic ammonium ion-selective electrodes [6–8]. 
Notably, phosphate esters, such as tris(2-ethylhexyl) phosphate (TEHP), showed 
high selectivity toward primary organic ammonium ions through the interaction 
between NH3+ groups of the organic ammonium ions and the negatively polarized 
oxygen atoms in the P=O groups of phosphate esters [7, 8].  
Mexiletine, an antiarrhythmic drug, is one of the primary amines that 
needs monitoring in terms of its concentration in body fluids [9, 10]. The chemical 
structure of mexiletine, together with those of other antiarrhythmic drugs tested 
in this study, is shown in Fig. 1. To develop this electrode, the combination of an 
ion-exchanger, sodium 
tetrakis[3,5-bis(2-methoxyhexafluoro-2-propyl)phenyl]borate (NaHFPB), and a 
solvent mediator, o-nitrophenyl octyl ether (NPOE), was effective, because the 
mexiletine electrode made with such a combination showed good selectivity 
toward Na+ present at high levels in body fluids [10]. However, the electrode 
made using NPOE responded to pharmaceutical substances in terms of their 
lipophilicity, with more lipophilic ions inducing serious interference with the 
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electrode’s response [10]. This was a general feature of ion-selective electrodes 
based on the combination of ion-exchangers and solvent mediators [11, 12]. Thus, 
we were particularly interested in examining the effect of solvent mediators 
containing a P=O group, such as TEHP, expecting to induce a strong interaction 
with the NH3+ group of mexiletine. We used a series of phosphorus compounds 
shown in Fig. 2.  Among them, S,S,S-tris(2-ethylhexyl) phosphorotrithioate (5) 
showed the highest sensitivity to mexiletine in phosphate-buffered physiological 
saline containing 0.15 mol L–1 NaCl and 0.01 mol L–1 NaH2PO4/Na2HPO4 (pH 7.4), 
giving a detection limit of 2×10–6 mol L–1 with a slope of 58.8 mV decade–1. Under 
physiological conditions with a high concentration of NaCl, this is the best 
detection limit of any mexiletine electrode developed to date [10, 13, 14]. The 
interference from lipophilic organic ammonium ions was remarkably improved 
compared to the case of NPOE. We applied the electrode to the determination of 
mexiletine concentrations in saliva.  The results compared favorably with those 
obtained by high-performance liquid chromatography [15]. 
 
Experimental 
 
Reagents 
 
     S,S,S-Tris(2-ethylhexyl) phosphorotrithioate (5), 
tris(2-ethylhexyl)phosphine oxide (4), and 2-ethylhexyl 
bis(2-ethylhexyl)phosphinate (3) were synthesized by Wako (Osaka, Japan) 
according to procedures similar to those described previously [16–19]. Other 
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chemicals were obtained from commercial sources: bis(2-ethylhexyl) 
2-ethylhexylphosphonate (2) was from Chem Service (West Chester, PA, USA); 
TEHP (1) and NPOE were from Fluka (Buchs, Switzerland); NaHFPB was from 
Dojindo Laboratories (Kumamoto, Japan); poly(vinyl chloride) (PVC; degree of 
polymerization, 1020) was from Nacalai Tesque (Kyoto, Japan); mexiletine 
hydrochloride, N-acetylprocainamide hydrochloride, bretylium tosylate, 
disopyramide phosphate, lidocaine hydrochloride, procainamide hydrochloride, 
quinidine hydrochloride monohydrate, and sotalol hydrochloride were from 
Sigma (St. Louis, MO, USA); and tocainide hydrochloride was from USP 
(Rockville, MD, USA). All other chemicals were of analytical reagent grade. 
 
Electrode system 
 
     A PVC matrix-type ion-selective membrane was prepared using procedures 
described previously [6, 7, 10]. The components of the sensor membrane were 
NaHFPB (0.5 mg), solvent mediator (20 mg), and PVC (30 mg).  Compared to 
the traditional ratio for sensor membranes using about 66% (w/w) solvent 
mediator and about 33% (w/w) PVC [6, 7, 10, 11], the amount of PVC was 
increased in this study, which improved remarkably the electrode’s sensitivity as 
will be discussed in the results and discussion section. The materials were 
dissolved in tetrahydrofuran (about 1 mL) and poured into a flat Petri dish (16 
mm in diameter) made by Asahi Seisakusho (Ohtake, Hiroshima, Japan). The 
solvent was then evaporated off at room temperature. The resulting membrane 
was excised and attached to a PVC tube (4 mm o.d., 3 mm i.d.) with 
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tetrahydrofuran adhesive. The PVC tube was filled with an internal solution 
composed of 1×10–4 mol L–1 mexiletine hydrochloride, 0.01 mol L–1 NaCl, and 0.01 
mol L–1 NaH2PO4/Na2HPO4 (pH 7.4), and the sensor membrane was conditioned 
overnight. The electrochemical cell arrangement was Ag, AgCl/internal 
solution/sensor membrane/sample solution/1 mol L–1 NH4NO3 (salt bridge)/0.01 
mol L–1 KCl/Ag,AgCl. The internal solution was the same as that used to 
condition the membrane. Potential measurements were made with a voltmeter 
produced by a field-effect transistor operational amplifier (LF356; National 
Semiconductor, Sunnyvale, CA, USA; input resistance >1012 Ω) connected to a 
recorder. To examine the pH-dependence of the electrode, a miniature pH glass 
electrode (1826A-06T; Horiba, Kyoto, Japan), together with test and reference 
electrodes, was immersed in each sample solution to simultaneously measure the 
solution pH.  
 
Evaluation of the electrode’s performance 
 
     The detection limit was defined as the intersection of the extrapolated 
linear regions of the calibration graph [6, 7, 10, 20].  The selectivity coefficients 
of the electrode ( ) were determined by a separate solution method [6, 7, 10, 20, 
21] using respective chloride salts, except for disopyramide and bretylium, for 
which we used phosphate and tosylate salts, respectively. The concentrations 
were adjusted to 0.01 mol L–1. In order to obtain the selectivity coefficients under 
physiological conditions, we adjusted the pH of the solution to 7.4 by adding a 
small amount of NaOH. The coexistence of a minute amount of NaOH little 
Pot
, jik
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affected the estimation of the selectivity coefficient of each ion. The coefficients 
were calculated from the equation, 
log  = (Ej – Ei)/S + log ci – log cj 1/zj, Pot, jik
where Ei and Ej represent the e.m.f. readings measured for mexiletine and the 
interfering ion, respectively, S is the theoretical slope of the electrode for 
mexiletine (59.2 mV decade–1 at 25oC), ci and cj are the concentrations of 
mexiletine and the interfering ion, respectively, and zj is the charge of the 
interfering ion. All measurements were performed at room temperature (about 
25oC). 
 
Collection of saliva 
 
     Saliva secreted in the buccal cavity (defined as mixed saliva or whole saliva) 
was collected for 5 min by means of continuous mouth and tongue movement [22, 
23]. Pre-saliva (i.e. residual saliva in the buccal cavity) was discarded before the 
periodical collection of saliva. After stimulation, the salivated fluid (i.e. mixed 
saliva) accumulated in the mouth cavity was expectorated into a beaker, 
transferred to a plastic tube, and centrifuged at 1200×g for 10 min to remove the 
mucosal tissue debris. The saliva supernatant obtained was frozen at –20oC until 
use. 
 
Assay procedure 
 
     A typical mexiletine assay in saliva proceeded as follows. The electrodes 
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were placed in 200 μL of saliva and constantly stirred with a bar. This electrode 
system, including the reference electrode [24], is compact. Therefore, a volume as 
low as 200 μL can be assayed. Samples containing mexiletine were prepared by 
adding mexiletine hydrochloride to the saliva. Between measurements, the 
electrode was soaked in distilled water and wiped. The electrode was stored in a 
solution of 1×10–4 mol L–1 mexiletine hydrochloride, 0.01 mol L–1 NaCl, and 0.01 
mol L–1 NaH2PO4/Na2HPO4 (pH 7.4), when not in use. All measurements were 
performed at room temperature (about 25oC). 
 
High-performance liquid chromatography  
 
     Mexiletine concentrations in the saliva samples were also determined by 
means of high-performance liquid chromatography with several modifications of 
a previous method [15]. The system consisted of a Shimadzu SCL-6B system 
controller (Kyoto, Japan) equipped with an LC-9A pump, an SPD-6A UV 
spectrophotometric detector, and a C-R4A chromatopac integrator. The samples 
(50 µL) were injected into an Inertsil ODS-80A column (150×4.6 mm i.d.; GL 
Sciences, Tokyo, Japan) maintained at 40°C. The elution was performed 
isocratically with 0.02 mol L–1 KH2PO4/acetonitrile (75:25, v/v) at a flow rate of 
1.0 mL min–1.  The UV wavelength was fixed at 210 nm. 
 
Results and discussion 
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Response characteristics of the electrodes 
 
     We previously used NPOE as a solvent mediator to construct a 
mexiletine-sensitive membrane electrode [10]. This electrode had markedly 
suppressed responses to inorganic cations, such as Na+ and K+, but suffered 
marked interference from many lipophilic antiarrhythmic drugs [10]. The 
interference by lipophilic amines is characteristic of an ion-selective electrode 
prepared with an ion-exchanger [10–12, 14]. However, we recently found that 
some solvent mediators with hydrogen bond-forming ability can strongly enhance 
the response to certain specific organic ammonium ions, even in combination 
with an ion-exchanger [6–8]. Notably, phosphate esters, such as TEHP (1), 
showed high selectivity toward primary organic ammonium ions through the 
interaction between NH3+ groups of organic ammonium ions and the negatively 
polarized oxygen atoms in the P=O groups of phosphate esters [7, 8]. Thus, we 
first paid attention to whether TEHP would act as an effective solvent mediator 
for mexiletine. Fig. 3 shows a comparison of two solvent mediators, TEHP and 
NPOE, based on potentiometric ion selectivity coefficients. An electrode made 
from TEHP showed high selectivity toward mexiletine, with little interference by 
lipophilic quaternary ammonium ions, such as (C3H7)4N+; however, the ability of 
TEHP to discriminate inorganic ions, such as Na+, was much lower than that of 
NPOE. Thus, it is important to improve the ability to discriminate especially 
between Na+ and mexiletine, because we wish to use the electrode to determine 
levels of mexiletine under physiological conditions with a high concentration of 
NaCl. 
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     To obtain a highly sensitive mexiletine electrode, we first considered 
suppressing the transfer of mexiletine in the PVC membrane from the inner 
electrolyte solution to the outer surface of the PVC membrane, because such a 
transfer of an analyte ion is now known to be greatly affected by the sensitivity of 
the electrode [25, 26]. To suppress this transfer, we increased the amount of PVC 
in the sensor membrane to increase the membrane’s thickness and hardness. Fig. 
4 shows calibration graphs of three typical electrodes with different amounts of 
PVC. The graphs were obtained by measuring known amounts of mexiletine 
hydrochloride added to phosphate-buffered physiological saline containing 0.15 
mol L–1 NaCl and 0.01 mol L–1 NaH2PO4/Na2HPO4 (pH 7.4) and plotting the 
concentrations against the corresponding potential values. The measurements 
were performed over a concentration range of 1×10–8 to 1×10–3 M mexiletine. As 
was expected, an increase in PVC content in the sensor membrane greatly 
improved the sensitivity of the mexiletine electrode. Further increases in PVC 
content above 30 mg were difficult, because such a membrane was very hard and 
it was difficult to stick the membrane to the PVC tube with THF as adhesive. 
Thus, we chose 30 mg as the amount of PVC for further studies and the 
components of the sensor membrane were as described in the experimental 
section. 
Then, we examined the influence of substituents bound to P=O groups 
using compounds 1–4, shown in Fig. 2, because the basicity of the oxygen atom in 
the P=O group is known to be greatly affected by the replacement of an alkoxy 
group with an alkyl group [6, 27]. Thus, increasing the number of 
electron-donating alkyl substituents would produce a more negative charge at 
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the oxygen atom in the P=O group, making a stronger interaction with the NH3+ 
group of organic ammonium ions including mexiletine. The response 
characteristics of these electrodes are summarized in Table 1, along with those of 
S,S,S-tris(2-ethylhexyl) phosphorotrithioate (5) which will be discussed later. As 
expected, the sensitivity of electrodes improved in the order 1 < 2 < 3 < 4, as the 
number of alkyl substituents bound to the P=O group increased. This suggested 
that increases in the number of electron-donating alkyl substituents produced a 
more negative charge at the oxygen atom in the P=O group, making a stronger 
interaction with the NH3+ group of mexiletine. To obtain more detailed 
information on the electrode made using 4, we evaluated the selectivity 
coefficients for various antiarrhythmic drugs, shown in Fig. 1, as well as organic 
and inorganic cations examined in Fig. 3. As shown in Fig. 5, the electrode based 
on 4 exhibited the highest selectivity toward mexiletine among various 
antiarrhythmic drugs. However, the electrode suffered marked interference from 
H+. This indicated that an increase in basicity also promoted the function of 4 as 
a H+ receptor. 
Then, we were interested in examining S,S,S-tris(2-ethylhexyl) 
phosphorotrithioate (5). This solvent mediator was expected to suppress the 
interference from H+ and to enhance the response to mexiletine, because the 
presence of a sulfur atom gave weaker basicity than 4 and also increased the 
response to lipophilic primary organic ammonium ions [28]. It was found that the 
electrode made using 5 showed the highest sensitivity to mexiletine in 
phosphate-buffered physiological saline containing 0.15 mol L–1 NaCl and 0.01 
mol L–1 NaH2PO4/Na2HPO4 (pH 7.4) (Table 1). Comparison of the selectivity 
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coefficients of the electrodes made using 4 and 5 revealed differences in the 
response characteristics in more detail as shown in Fig. 5. The electrode made 
from 5, which showed the highest sensitivity to mexiletine in phosphate-buffered 
physiological saline, had a more suppressed response to H+ and alkali metal 
cations including Na+ than that made from 4. However, the electrode made from 
5 induced a stronger response to lipophilic quaternary ammonium ions, such as 
(C3H7)4N+ and bretylium, as well as quinidine than the electrode based on 4. This 
result was consistent with the fact that the presence of a sulfur atom generally 
enhances the response to lipophilic organic ammonium ions [8, 28, 29]. 
Mexiletine is also lipophilic among primary ammonium ions, and thus the 
electrode made using 5 had a strengthened response to mexiletine. Although this 
electrode suffered a large degree of interference from quinidine, it still showed 
much less interference from various other antiarrhythmic drugs than that made 
of NPOE reported previously [10]. Hence, we conclude that 
S,S,S-tris(2-ethylhexyl) phosphorotrithioate (5) produced a sensitive response to 
mexiletine for the following reasons: (a) the specific interaction of the negatively 
polarized oxygen atom in the P=O group in 5 with the NH3+ group of mexiletine 
and (b) the presence of the sulfur atom of 5 enhancing the recognition of 
lipophilic mexiletine.  
     We examined the pH-dependence to determine the effective pH range for 
the electrodes based on 4 and 5. The pH of the solution was adjusted by adding 
an appropriate amount of dilute hydrochloric acid or sodium hydroxide solution. 
The measurements were performed in the presence of 0.15 mol L–1 NaCl. As 
shown in Fig. 6, it was clear that the electrode made using 4 suffered a greater 
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degree of interference with the response to mexiletine in the acidic pH range. 
Thus, S,S,S-tris(2-ethylhexyl) phosphorotrithioate (5) was a better solvent 
mediator than 4 in terms of pH insensitivity. Decreases in potential above pH 9, 
observed for both electrodes, were attributable to an increase in the 
concentration of unprotonated amine, as the pKa of mexiletine has been reported 
to be 9.15 [30]. The response time (90% of the final signal) of the electrode using 
5 was below 10 s when the concentration of mexiletine hydrochloride was 
changed from 5×10–6 to 1×10–5 mol L–1. 
 
Application of the electrode to clinical analysis 
 
     We are particularly interested in the application of the electrode to drug 
monitoring in body fluids. The clinical range of mexiletine in serum required for 
antiarrhythmic therapy was 0.7–2 mg L–1 (4×10–6–1.1×10–5 mol L–1) [9]. However, 
this concentration was near to the detection limit measured in 
phosphate-buffered physiological saline and the sensitivity of the present 
electrode was insufficient to determine mexiletine levels in serum samples. 
Recently, increased attention has been paid to the use of saliva samples in 
place of blood samples for therapeutic drug monitoring in view of the advantage 
of noninvasive sample collection procedures [22, 23, 31–34]. Mexiletine 
concentrations were reported to be significantly higher in saliva than in serum 
(by the factor of 3–8) [22, 23]. Thus, the therapeutic concentration range becomes 
higher in saliva samples, exceeding 1×10–5 mol L–1, and much easier monitoring 
of this drug by the present electrode was expected. We measured a calibration 
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graph of mexiletine in saliva and compared it with that in phosphate-buffered 
physiological saline. As shown in Fig. 7, similar calibration graphs were obtained 
for saliva and the physiological saline. This is because saliva also contained high 
concentrations of inorganic ions such as Na+ and K+ at levels of 0.01–0.02 mol L–1 
and a neutral pH of around 6.8–7.2 [22, 32], similar to the situation in the 
physiological saline. The slope and the detection limit in saliva were 58.1 mV 
decade–1 and 2×10–6 mol L–1, respectively. It should be emphasized, however, that 
the determination of mexiletine concentrations down to 1×10–6 mol L–1 was still 
easier with an appropriate calibration as shown in Fig. 7. The sensitivity of the 
electrode was adequate for measuring therapeutic mexiletine levels in saliva. The 
response time of the electrode (90% final signal) was below 10 s when the 
concentration of mexiletine was changed from 5×10–6 to 1×10–5 mol L–1. We 
determined the mexiletine concentrations in saliva samples using the calibration 
graph (Fig. 7, closed circle) and compared the results with those determined by 
high-performance liquid chromatography. Linear regression analysis of 
mexiletine concentrations (2×10–6–4×10–5 mol L–1) measured by the mexiletine 
electrode against values obtained by high-performance liquid chromatography 
showed a good correlation. The slope and the intercept of the line were 1.03 and 
0.193, respectively (r = 0.974, n = 38). 
As already mentioned by others, the use of an ion-selective electrode has 
inherent advantages over various other analytical methods, because it requires 
no special sample pretreatment, the analysis time is shorter, and the necessary 
equipment is inexpensive. This method will provide a new means of estimating 
mexiletine levels in saliva samples.  
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Conclusions 
 
     We demonstrated that S,S,S-tris(2-ethylhexyl) phosphorotrithioate is a new 
solvent mediator, especially useful for constructing a mexiletine-sensitive 
membrane electrode. This new electrode afforded the best detection limit under 
physiological conditions of any mexiletine electrode developed to date [10, 13, 14]. 
Using the electrode, we measured therapeutic mexiletine levels in saliva. 
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Table 1  Comparison of the performance of electrodes in response to mexiletine a 
 
                                                 Slope       Detection limit 
       Solvent mediator                       (mV decade–1)      (mol L–1) 
 
Tris(2-ethylhexyl) phosphate (1)                   54.2          5×10–6 
Bis(2-ethylhexyl) 2-ethylhexylphosphonate (2)      55.7          4×10–6 
2-Ethylhexyl bis(2-ethylhexyl)phosphinate (3)       55.5          3×10–6 
Tris(2-ethylhexyl)phosphine oxide (4)               57.0          3×10–6 
S,S,S-Tris(2-ethylhexyl) phosphorotrithioate (5)     58.8          2×10–6 
    
a All measurements were performed in the concentration range of 1×10–8 to 
1×10–3 mol L–1 mexiletine hydrochloride in 0.15 mol L–1 NaCl and 0.01 mol L–1 
NaH2PO4/Na2HPO4 (pH 7.4). 
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Figure Legends 
 
Fig. 1  Chemical structures of mexiletine and the antiarrhythmic drugs tested. 
 
Fig. 2  Chemical structures of the phosphorus compounds tested. 
 
Fig. 3  Comparison of the selectivity coefficients of electrodes based on TEHP 
and NPOE. 
 
Fig. 4  Effects of PVC contents on the responses of electrodes to mexiletine in a 
solution containing 0.15 mol L–1 NaCl and 0.01 mol L–1 NaH2PO4/Na2HPO4 (pH 
7.4). The amounts of PVC were (a) 10 mg, (b) 20 mg, and (c) 30 mg, while the 
amounts of TEHP (20 mg) and NaHFPB (0.5 mg) were unchanged.  
 
Fig. 5  Comparison of the selectivity coefficients of electrodes made using 
tris(2-ethylhexyl)phosphine oxide (4) and S,S,S-tris(2-ethylhexyl) 
phosphorotrithioate (5).  
 
Fig. 6  Effects of pH on the response to mexiletine of the electrodes made using 
tris(2-ethylhexyl)phosphine oxide (4) and S,S,S-tris(2-ethylhexyl) 
phosphorotrithioate (5) in the presence of 0.15 mol L–1 NaCl. The pH of the 
solution was changed by adding an appropriate amount of dilute hydrochloric 
acid or sodium hydroxide solution.  
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Fig. 7  Comparison of the response of electrodes to mexiletine in 0.15 mol L–1 
NaCl and 0.01 mol L–1 NaH2PO4/Na2HPO4 (pH 7.4) (○) and saliva (●). 
 
